An Evidence-Based Review of Fremanezumab for the Treatment of Migraine Ivan Urits Gavin Clark Daniel An Bredan Wesp Rebecca Zhou Ariunzaya Amgalan Amnon A. Berger Hisham Kassem Anh L. Ngo Alan Kaye Rachel J. Kaye Elyse M. Cornett Omar Viswanath 10.6084/m9.figshare.11890503.v1 https://adisjournals.figshare.com/articles/figure/An_Evidence-Based_Review_of_Fremanezumab_for_the_Treatment_of_Migraine/11890503 <p></p><p>The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.<b> </b></p><br><p></p> 2020-03-13 15:40:23 Chronic pain CGRP Fremanezumab Headache Migraine Monoclonal antibody